TVARDI THERAPEUTICS, INC. Debt Securities, Available-for-sale, Allowance for Credit Loss, Writeoff
TVARDI THERAPEUTICS, INC. (TVRD) reported Debt Securities, Available-for-sale, Allowance for Credit Loss, Writeoff of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff · last filed 2026-08-14
- TVARDI THERAPEUTICS, INC. debt securities, available-for-sale, allowance for credit loss, writeoff for the quarter ending 2026-06-30 was $0.00.
- TVARDI THERAPEUTICS, INC. debt securities, available-for-sale, allowance for credit loss, writeoff for the quarter ending 2026-03-31 was $0.00.
- TVARDI THERAPEUTICS, INC. debt securities, available-for-sale, allowance for credit loss, writeoff for the quarter ending 2025-12-31 was $0.00.
- TVARDI THERAPEUTICS, INC. debt securities, available-for-sale, allowance for credit loss, writeoff for the quarter ending 2025-09-30 was $0.00.
- TVARDI THERAPEUTICS, INC. debt securities, available-for-sale, allowance for credit loss, writeoff for fiscal 2025 was $0.00.
- TVARDI THERAPEUTICS, INC. debt securities, available-for-sale, allowance for credit loss, writeoff for fiscal 2024 was $0.00.
| Period end | Debt Securities, Available-for-sale, Allowance for Credit Loss, Writeoff 3 month | Debt Securities, Available-for-sale, Allowance for Credit Loss, Writeoff 6 month | Debt Securities, Available-for-sale, Allowance for Credit Loss, Writeoff 9 month | Debt Securities, Available-for-sale, Allowance for Credit Loss, Writeoff 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $0.00 derived: sum of 3 quarters · filed 2026-05-08 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $0.00 derived: sum of 3 quarters · filed 2026-05-08 | $0.00 derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $0.00 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |